⌘K

Login Start Free

Home/Filings/4/0001358403-16-000220

4//SEC Filing

BELLICUM PHARMACEUTICALS, INC 4

Accession 0001358403-16-000220

CIK 0001358403operating

View on SEC.gov Company Profile

Filed

Jun 16, 8:00 PM ET

Accepted

Jun 17, 4:10 PM ET

Size

5.4 KB

Accession

0001358403-16-000220

Insider Transaction Report

Form 4

Period: 2016-06-15

BELLICUM PHARMACEUTICALS, INCBLCM

Director

Transactions

Award
Stock Option (right to buy)
2016-06-15+10,000→ 10,000 total
Exercise: $12.44Exp: 2026-06-14→ Common Stock (10,000 underlying)

Footnotes (1)

[F1]The shares subject to the option vest and become exercisable in equal monthly installments until the Issuer's 2017 annual meeting of stockholders.

Documents

1 file

4
wf-form4_146619422324517.xmlPrimary
FORM 4

Issuer

BELLICUM PHARMACEUTICALS, INC

CIK 0001358403

Entity typeoperating

Related Parties

1

filerCIK 0001358403

Filing Metadata

Form type: 4
Filed: Jun 16, 8:00 PM ET
Accepted: Jun 17, 4:10 PM ET
Size: 5.4 KB

View on SEC.gov